TVTX Travere Therapeutics, Inc.: institutional ownership and insider trading
339 funds reported holding $6.76B of Travere Therapeutics, Inc. in their latest 13F filings; in Q2 2026 funds net bought $91.4M, with 85 new positions and 29 funds selling out; over the last 12 months insiders bought $0 and sold $117M on the open market.
Famous investors holding TVTX
- Renaissance Technologies (Renaissance Technologies): $104M, 0.1% of the portfolio
- Two Sigma (Two Sigma Investments): $88.9M, 0.1% of the portfolio
- D. E. Shaw (D. E. Shaw & Co.): $81.8M, 0.0% of the portfolio
- Ken Griffin (Citadel Advisors): $13.3M, 0.0% of the portfolio
- Izzy Englander (Millennium Management): $4.81M, 0.0% of the portfolio
Largest institutional holders of TVTX
- Jupiter Topco LLC — $643M
- BlackRock, Inc. (BLK) — $456M
- FMR LLC — $403M
- JANUS HENDERSON GROUP PLC (JHG) — $339M
- BANK OF AMERICA CORP /DE/ (BAC, BAC-PB, BAC-PE, BAC-PK, BAC-PL, BAC-PM, BAC-PN, BAC-PO, BAC-PP, BML-PG, BML-PH, BML-PJ, BML-PL) — $260M
- STATE STREET CORP (STT, STT-PG) — $242M
- VANGUARD GROUP INC — $241M
- VANGUARD CAPITAL MANAGEMENT LLC — $233M
- PERCEPTIVE ADVISORS LLC — $213M
- NOMURA ASSET MANAGEMENT INTERNATIONAL INC. — $160M
Recent TVTX insider trades
- Oct 15, 2026: Dube Eric M sold 243,735 shares ($13.1M)
- Sep 17, 2026: Dube Eric M sold 400,000 shares ($25.4M)
- Sep 17, 2026: Heerma Peter sold 283,189 shares ($17.9M)
- Sep 16, 2026: Rote William E. sold 209,048 shares ($13.1M)
5%+ owners
- FMR LLC: 7.7% (Schedule 13G/A, filed Aug 6, 2026)
- BANK OF AMERICA CORP /DE/: 5.8% (Schedule 13G, filed Aug 12, 2026)
- Vanguard Capital Management: 5.1% (Schedule 13G, filed Apr 30, 2026)